Azurin
| Azurin | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| CDD | cd13922 | ||||||||
| |||||||||
Azurin is a small, periplasmic, bacterial blue copper protein found in Pseudomonas, Bordetella, or Alcaligenes bacteria. Azurin moderates single-electron transfer between enzymes associated with the cytochrome chain by undergoing oxidation-reduction between Cu(I) and Cu(II). Each monomer of an azurin tetramer has a molecular weight of approximately 14kDa, contains a single copper atom, is intensively blue, and has a fluorescence emission band centered at 308 nm.
Azurins and pseudoazurins participate in the
Although unrelated to its electron-transfer property, azurin has been found to have anticancer properties through its interaction with tumor-suppressor protein p53.
Protein function
In its oxidized form, azurin (Cu2+Az) receives an electron from its redox partner and is reduced according to the following reaction:
- Cu2+Az + e− → Cu+Az
The redox potential is 310 mV.[3]
The highly-interconnected beta-sheet structure of azurin is strongly coupled with its electron-transfer center (the copper-binding side).[4] Considerable experimental evidence exists to suggest that hydrogen bonds play a role in the long-distance electron transfer mechanism of azurin. Taken together, these observations suggest that electrons tunnel through the protein along its polypeptide and hydrogen bonds, making azurin a useful model system for studying long-range, intraprotein electron transfer (LRET).[4]
Protein structure
Azurin is a monomeric protein that weighs approximately 14 kDa and is composed of 128 amino acids forming eight beta-strands arranged in a beta-barrel formation.[5] The strands are connected by turns and a single alpha-helical insertion.[5] A single-atom copper binding site is located about 7 Å below each monomer’s surface towards its northern end; the copper atom that inhabits it is coordinated by five ligands surrounded by an extensive hydrophobic patch.[6]
The three equatorial copper ligands are composed of a thiolate (Cys112) and two imidazoles (His46, His117), and the carbonyl oxygen atoms of Gly45 and Met121 serve as the two weak axial ligands.[5] With the exception of Gly45, the copper-binding configuration above is common to the structures of all blue type 1 copper-binding proteins determined thus far.[7] Once coordinated, the ligand-metal complex assumes a distorted, trigonal bi-pyramidal geometry that stabilizes the cuprous (Cu(I)) reduced state of the protein relative to the cupric (Cu(II)) oxidized state.[5] Structurally imposed backbonding between the copper d orbitals and its ligand p orbitals may further stabilize the cuprous state.[8]
Existing structural information about azurin has largely been derived from X-ray crystallography studies of single-site mutated forms of the protein. Notable structural features elucidated by crystallography include the beta-sandwich motif formed from eight interlocking beta strands,[5] as well as an alpha-helical segment outside the barrel linking beta-sheets 4 and 5.[5]
Although the Cu(I)/Cu(II) redox potential is typically higher for azurin than most other copper complexes, structural studies in which Met121 (one of azurin’s equatorial copper-coordinating ligands) is replaced have demonstrated that the absence of a thiolate copper ligand does not preclude high reduction potentials, as large hydrophobic residues in position 121 also raise the redox potential of the copper atom.[8] Thus, the higher redox potentials have been attributed to the exclusion of water from the metal-binding site, a condition augmented by the presence of bulky hydrophobic residues.[8]
Conversely, negatively charged residues lower the redox potential, since they stabilize the more positively charged cupric form of the copper ion.[8]
Biological function
When expressed in nitrogen-fixing organisms, azurin serves as the electron donor to nitrite reductase, an enzyme in the denitrification pathway of the nitrogen cycle.[9]
Azurins support oxidative deamination of primary amines by passing electrons from aromatic amine dehydrogenase to cytochrome oxidase, as well as from some c-type cytochromes to nitrite reductases.[10]
Disease relevance
Azurin has garnered significant attention as a potential therapeutic for various diseases, including cancer.[11] In vivo, it has been demonstrated to induce regression of human melanoma and breast cancer tissue with minimal toxic effects to the organism.[11]
Azurin enters preferentially into cancer cells via the p28 domain of the enzyme, which roughly corresponds to the extended alpha-helical region of the enzyme. Although this pathway plays a significant role in azurin’s anticancer activity, the details of the interaction between azurin and p53 are not well understood.
A phase I clinical trial in the United States demonstrated both partial and complete tumor regression effects in fifteen stage IV cancer patients treated with the p28 amino-acid fragment of azurin.[13] Another phase I trial with the p28 fragment demonstrated azurin’s therapeutic effects against pediatric patients with brain tumors; subsequently, the USFDA approved the designation of p28 as an orphan drug for glioma.[14]
Azurin’s other domains may also exhibit strong anticancer activity by binding to cell surface receptor tyrosine kinases such as EphB2 receptors, which induce angiogenesis in cancer cells.[14] This is another mechanism by which azurin has been proposed to exhibit its therapeutic effects.